Regression analysis showed significant linear trend suggesting
albumin as a variable is an important factor affecting change in CD4 count (p=0.01)
However importance of serum albumin in predicting risk of FN has not been documented, so in order to analyze the role of serum
albumin as an independent risk factor for FN we conducted this study and in order to minimize the bias for other risk factors i.e.
However, the performance of fructosamine and glycated
albumin as prognostic markers in patient populations with CKD, ESRD, or other conditions remains unclear.
Sakuta, "Ischemia-modified
albumin as a marker of myocardium and skeletal muscle damage," International Cardiovascular Research Journal, vol.
Albumin as Early Predictor of Persistent Organ Failure and Mortality.
Dextran-70 versus
albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis.
The use of
albumin as a replacement fluid is controversial, mainly due to the cost implications as well as the potential for transmission of blood-borne viral disease such as Creutzfeldt-Jacob Disease (CJD).
Review article:
albumin as a drug--biological effects of albumin unrelated to oncotic pressure.
The use of
albumin as a carrier of bioactive small molecules, or co-factors, including metal ions in improving cell growth and performance has shown that albumin contributes to the efficacy of many of these molecules in improving cell performance.
There have been several studies in the western world including interventional studies trying to explore the scope of
albumin as a neuroprotective agent.
The most extensive investigations of glycated
albumin as a diagnostic test come from studies conducted in China and Japan (8, 9, 11, 13).
However, for over a decade, the healthcare industry has been exploring the use of human
albumin as a non-therapeutic substance/excipient for commercial settings.